Post by
Pareto8020 on Dec 04, 2023 11:24am
Allergan slow walking this to market.
The fact Sirona hasn't even received a milestone payment yet doesn't bode well for an imminent launch of a product. They'd have to announce receipt of milestone payment as it would be material and that would indicate a product launch was near.
Hopefully Howie put some requirements into the contract forcing Allergan to move forward and hit some timelines or penalties would be payable but I think he basically bent over and gave them whatever they dictated. Fingers crossed it's not another Wanbang scenario where they take so long it becomes useless to bother moving forward with anything.
So the milestone should be the trigger for the larger investing herd to jump on the Sirona train - until then Howard hasn't given anyone a compelling reason to invest in SBM unless they are gluttons for punishment.
Comment by
MirrorWorldMan on Dec 04, 2023 5:13pm
Who gives a house of lighteners away without adequate upfront and then issues stock to pay bills. It's a replayed scenario unfortunately and there is no indication it will ever end. Howie's hopes and confidences mean less than zero.
Comment by
lscfa on Dec 04, 2023 6:40pm
R&F paid $50,000 & $50,000 USD for upfront and milestone. I suspect Alleragn is $500,000 & $500,000 USD. This will not sustain SBM.